LinkedIn Image

2017 Progress and Controversies in Gynecologic Oncology Conference

Register Now

Meeting Overview

Join the world’s leading gynecologic oncology experts at the 2017 Progress and Controversies in Gynecologic Oncology Conference in Barcelona. Get interactive updates on practice-changing clinical trial data in a format fostering discussions that will impact clinical outcomes for patients.

We look forward to welcoming you to the conference.

Sincerely,

Andreas du Bois, MD, PhD
Chair
Stanley B. Kaye, MD
Chair
Ignace Vergote, MD, PhD
Chair
Foto-Prof-du-Bois kaye Ignace-Vergote

Target Audience

The 2017 Progress and Controversies in Gynecologic Oncology Conference is intended for gynecologists, oncologists, radiation therapists, surgeons, pathologists, and other practitioners, including allied health professionals involved in the diagnosis and management of gynecologic malignancies.

Learning Objectives

After successful completion of this educational activity, participants should be able to:

  • Describe optimal surgical techniques for the management of vulvar cancer
  • Develop practical approaches for the management of cervical cancer and endometrial cancer
  • Assess standard and emerging therapeutic options for ovarian cancer and describe how the options impact patient outcomes
  • Explain the role of fertility sparing therapy in gynecologic malignancies

Continuing Education

2017 Progress and Controversies in Gynecologic Oncology Conference is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. 2017 Progress and Controversies in Gynecologic Oncology Conference is designated for a maximum of 9 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.

Disclosures

Disclosure of Relevant Financial Relationships

prIME Oncology assesses the relevant financial relationships of its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. Any potential conflicts of interest that are identified are thoroughly vetted by prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prIME Oncology is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.

Meeting Chairs

Andreas du Bois, MD, PhD
Kliniken Essen-Mitte
Essen, Germany
Stanley B. Kaye, MD
The Royal Marsden Hospital
Sutton, United Kingdom
Ignace Vergote, MD, PhD
University Hospitals Leuven
Leuven, European Union

Scientific Committee

Nicoletta Colombo, MD
University of Milan-Bicocca
Milan, Italy
Bradley J. Monk, MD, FACS, FACOG
Arizona Oncology (US Oncology Network)
University of Arizona College of Medicine-Phoenix
Creighton University School of Medicine
at St. Joseph’s Hospital
Phoenix, Arizona, United States
Andrés Poveda, MD
Fundación Instituto Valenciano de Oncología
Valencia, Spain
Eric Pujade-Lauraine, MD, PhD
Centre Hospitalier Universitaire Hôtel-Dieu
Paris, France

Faculty

Giovanni Aletti, MD
European Institute of Oncology
Milan, Italy
F. Xavier Bosch, MD, PhD, MPH
Institut Català d’Oncologia
Barcelona, Spain
Luis Chiva, MD, PhD
Clinica Universidad de Navarra
Madrid, Spain
Robert L. Coleman, MD, FACOG, FACS
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Christina Fotopoulou, MD, PhD
Imperial College London
London, United Kingdom
Antonio González-Martín, MD
MD Anderson Cancer Center Madrid
Madrid, Spain
Sileny Han, MD, PhD
University Hospitals Leuven
Leuven, Belgium
Philipp Harter, MD, PhD
Kliniken Essen-Mitte
Essen, Germany
Sven Mahner, MD, PhD
University of Munich
Munich, Germany
Christian Marth, MD, PhD
University Hospital Innsbruck
Innsbruck, Austria
Lukas Rob, MD, PhD
Charles University
Prague, Czech Republic
Adriaan Vanderstichele, MD
University Hospitals Leuven
Leuven, Belgium
Ate G. J. van der Zee, MD, PhD
University Medical Center Groningen
Groningen, the Netherlands

 

Agenda

Friday, 20 January 2017

13.00     Welcome and introduction

Session I: Lower Genital Tract Malignancies

13.10     Management of vulvar cancer

  • How to handle close margins and when to reoperate (25 min)
    Sven Mahner, MD, PhD
  • How to handle a positive sentinel node (25 min)
    Ate G. J. van der Zee, MD, PhD

14.00     Update on HPV vaccines
               F. Xavier Bosch, MD, PhD, MPH

14.30     Update on targeted therapy for cervical cancer, including immunotherapy
               Bradley J. Monk, MD, FACS, FACOG

15.00     Break

Session II: Uterine Cancer and Ovarian Cancer 

15.30     Lynch syndrome and uterine and ovarian cancer, including immunotherapy
               Robert L. Coleman, MD, FACOG, FACS

16.00     Systemic treatment of endometrial cancer: Are there any new agents in sight?
               Andrés Poveda, MD

Special Session: Hot Topics in Gynecologic Oncology

16.30     International co-operation in clinical trials: Past successes and future challenges
               Christian Marth, MD, PhD

16.55     Diagnostics and personalized medicine in high-grade serous ovarian cancer
               Adriaan Vanderstichele, MD

17.20     Day 1 concluding remarks and adjourn

Saturday, 21 January 2017 

08.30     Welcome and introduction

Session III: Ovarian Neoplasm I — Recurrence

08.35     Surgery of recurrent ovarian cancer: How to find the ideal setting?
               Andreas du Bois, MD, PhD

09.05     State of the art: Therapy in patients for whom platinum is an option
               Antonio González-Martín, MD

09.35     State of the art: Therapy in patients for whom platinum is not a good option
               Ignace Vergote, MD, PhD

10.05     Break

Session IV: Ovarian Neoplasm II — Emerging Concepts 

10.35     Intraperitoneal, hyperthermic intraperitoneal, and pressurized intraperitoneal aerosol chemotherapy, and others, revisited
               Philipp Harter, MD, PhD

11.05     Immune checkpoint modulators: Current status and future strategies
              Eric Pujade-Lauraine, MD, PhD

11.35     DNA repair inhibitors as targeted agents: Current status and future strategies
              Stanley B. Kaye, MD

12.05     Break

12.30     Industry-supported satellite symposium

13.45     Break

Session V: Ovarian Neoplasm III — Practical Issues 

14.00     How to define, evaluate, and identify surgical quality

  • Viewpoint of the ESGO Quality Assurance Committee (20 min)
    Giovanni Aletti, MD
  • For training young physicians (20 min)
    Luis Chiva, MD, PhD
  • For study groups and studies (20 min)
    Christina Fotopoulou, MD, PhD

15.00     Fertility sparing therapy in ovarian neoplasms
               Nicoletta Colombo, MD

15.30     Fertility sparing therapy in cervical and uterine cancers
              Lukas Rob, MD, PhD

16.00     Gynecological cancer in pregnancy
               Sileny Han, MD, PhD

16.30     Day 2 concluding remarks and adjourn

Registration

REGISTRATION FEES

Early Regular Late
Physician €375 €475 €575
Nurse €225 €300 €350
Fellow/Resident/Student €225 €300 €350
Industry €425 €525 €625

Registration fees include VAT.
*Support documentation of eligibility may be required.

Your registration fee will include:

  • Access to all sessions and exhibition
  • Lunch and coffee breaks
  • Congress documentation

Registration Deadlines
Early registration rate: 17 November 2016 (23.59 CET)
Regular registration rate: 5 December 2016 (23.59 CET)

To Register
You may register online through 18 January 2017 at www.prIMEoncology.org/gynconference2017. Registration confirmations will be issued upon successful completion of registration and reminders will be issued before the meeting. To preregister, registration and payment must be received no later than 17 November 2016 (early registration rate) or 5 December 2016 (regular registration rate). Please register onsite after 18 January 2017.

Group Registrations
Group registrations will be accepted. For more information, please contact: registrations.gyn2017@prIMEoncology.org.

Terms of Payment
All payments must be made in Euros. Payments can be made by credit card.

Registration will only be valid upon receipt of full payment by prIME Oncology. Outstanding payment must be settled onsite by credit card.

Cancellation
To receive a refund of registration fees, written notice of cancellation must be received at registrations.gyn2017@prIMEoncology.org.

The following deadlines and cancellation fee schedule will apply:

  • Before 10 November 2016: €50 administrative charge
  • From 10 November 2016: 60% cancellation fee applies on registration fee(s)
  • From 29 November 2016: 100% cancellation fee applies on registration fee(s)
  • Name changes from 29 November 2016: €15 fee is charged per change

Any registration fees remitted will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 28 November 2016.

prIME Oncology does not accept responsibility for reimbursement of travel, accommodation, or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

Hotel

A limited number of rooms are available at the Crowne Plaza Barcelona – Fira Center (meeting venue). Please make sure to make your bookings as quickly as possible through our online registration form.

Crowne Plaza Barcelona – Fira Center
Avenida Rius i Taulet, 1-3
Barcelona, Spain
Tel: +34 934 262 223

Check in time: 15.00
Check out time: 12.00

Double room for single occupancy €189, including breakfast and VAT
Double standard room €209, including breakfast and VAT
A booking fee of €15, will apply per room.

Room Booking
You can book your hotel room with the online registration form at the registration tab or at www.prIMEoncology.org/gynconference2017.

Cancellation fee hotel rooms:
A cancellation fee may apply in the event that a delegate cancels his/her (registration and) hotel accommodation. A written notice of cancellation must be received at registrations.gyn2017@prIMEoncology.org.

  • Until 15 October 2016: 60% of the total amount due is nonrefundable
  • From 16 October 2016: 100% of the total amount due is nonrefundable
  • From 29 November 2016: A modification fee of €15 applies for all changes

The amount of hotel room fees remitted will be refunded after the Congress. Substitutions are accepted with written notification. In case of no-shows a 100% cancellation fee of the entire stay will apply.

General Info

CONTACT
All inquiries related to the 2017 Progress and Controversies in Gynecologic Oncology Conference may be addressed to gyncongress2017@prIMEoncology.org.

EU OFFICE
Schenkkade 50, Suite 16
2595 AR The Hague
the Netherlands

Tel.: + 31 70 30 67 190
Fax: + 31 70 33 18 335
Web: www.prIMEoncology.org

ENTRY REQUIREMENTS
Most EU citizens only need their national identity card or passport to enter Spain. Non-EU citizens require a valid passport to enter Spain, but many countries are exempt from tourist visas. It is essential that you check with the Spanish embassy or consulate in your country before travelling. Without exception, passports must be valid for at least six months after your planned date of departure from Spain.

prIME Oncology will not directly contact embassies and consulates on behalf of applicants. It is the sole responsibility of the delegates to look after their visa requirements.

Note: Passport and visa requirements are liable to change at short notice. Travelers are advised to check their entry requirements with their embassy or consulate.

GETTING THERE
From Barcelona’s main international airport El Prat you can travel different ways to the Congress venue:

TAXI: Barcelona has 11,500 taxis easily identified by their yellow and black color. It takes 15-20 minutes, depending on traffic.

AEROBUS: This special service is clearly signposted at the stops outside the terminal and it takes you to different parts of the city. The Plaza de España stop is the closest to the hotel, approximately a 5-minute walk from the stop to the hotel.

TRAIN: The station is located to the west of the terminal. Trains go to Sants station. From here you can take either the metro 2 stops to Plaza de España and then a 10-15 minute walk or you can take a taxi.

CAR: Take the Castelldefels motorway (C-31) toward Barcelona to Plaza de España. Turn right on Avenida Maria Cristina and drive until you see the National Palace. Turn left on Avenida Rius i Taulet and carry on straight until Lleida Street. The hotel is right on the corner.

LOCAL TRANSPORT
Barcelona has a very good public transport system (TMB), with special ten-trip and one-day, two-day, and three-day tickets available for bus, metro, and local trains. You can call a taxi or flag them down in the streets. In many taxis you can also pay by credit card.

CLIMATE
Barcelona has a Mediterranean climate with mild, sunny winters, warm summers, and relatively low rainfall. In January, the average temperature is 13° Celsius (55.4° Fahrenheit).

TIME ZONE
Barcelona is in the Central European time zone (GMT +1).

LANGUAGE
Spanish and Catalan are the two main languages spoken in Barcelona. English is also widely spoken and to some extent French and German.

CURRENCY
The Spanish currency is the Euro (€).

TAXES
Value-added tax, or VAT, is otherwise known as IVA (impuesto sobre el valor añadido). The IVA is 10% on accommodation and restaurant prices and is usually, but not always, included in quoted prices. On retail goods the IVA is 21%. IVA-free shopping is available in duty-free shops at all airports for people travelling between EU countries.

TIPPING
Tips are already included in restaurant bills, but it is customary to round up an extra 5% to 10% if you are satisfied with the service. Porters are generally tipped €1 per bag.

Support

Several options are available to organizations interested in supporting this conference. For more information, please contact Katie Eustace by phone at +31 70 30 67 190, or by email at Katie.Eustace@prIMEoncology.org.

Register Now

DATE AND LOCATION

Friday, 20 January 2017
Saturday, 21 January 2017

Crowne Plaza Barcelona – Fira Center
Avda Rius I Taulet, 1-3
Barcelona, Spain

Provider

This activity is provided by prIME Oncology.

Sunshine Act and EFPIA Disclosure Code

prIME Oncology complies with all Sunshine Act reporting requirements as outlined by CMS and applicable manufacturers and with EFPIA Disclosure Code reporting requirements.